News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Test Tubes
Study sheds new light on DNA repair

16/03/14

A major study has given a new insight into how DNA is repaired – a fundamentally important process in all forms of life and diseases including cancer.
ICR Logo
New imaging approach fast tracks drug testing for incurable prostate cancer

14/03/14

Scientists have developed a new way to test the effectiveness of a drug for prostate cancer that has spread to the bone, which is currently incurable.
Professor Chris Marshall
ICR researcher wins Biochemical Society Centenary award

14/03/14

Professor Chris Marshall, Head of the Division of Cancer Biology, has won the prestigious Biochemical Society Centenary Award 2015.
Nandita deSouza in front of an MRI machine
Functional imaging: providing direction in the fight against cancer

11/03/14

People have been exploring with the help of magnetic fields ever since the twelfth century, when explorers first started using compasses to guide ships on cloudy nights.
ICR Logo
Mutations in leukaemia gene linked to new childhood growth disorder

09/03/14

Genetic mutations associated with leukaemia cause a newly described condition that affects growth and intellectual development in children.
ICR Logo
New computer software could spot cancer gene mutations

06/03/14

Scientists have developed a cutting-edge computer program that could be used to find as-yet undiscovered genetic mutations that cause cancer.
Glioblastoma cells
Breaking down the barriers to treating childhood cancer

04/03/14

Treatments for childhood cancer have improved greatly in recent decades – over 80% of children with cancer now survive their disease. But that figure, on the surface encouraging, hides the alarming truth that many children who do survive cancer are left with lifelong side-effects. As many as 40% of children who survive cancer are still suffering serious or even life-threatening side-effects 30 years after diagnosis.
ICR Logo
Scan measures cancer metabolites inside the body

03/03/14

Scientists have used a new scanning technique to measure the metabolites produced by tumours as a means of assessing their severity.
Andy Roast for the ICR, 2014
Using smart phone technology to deliver smart cancer treatments

27/02/14

When we pick up our smart phone and take a photo or video and share with our friends and family, most of us do not give a second thought about the technology we’re using. We owe this modern day given to something called a complementary metal-oxide-semiconductor (CMOS) sensor, also known as the active pixel sensor (APS).
ICR Logo
Scans of tumour ‘stiffness’ can assess response to cancer treatment

27/02/14

A new type of scan measuring whether tissues are ‘stiff’ or elastic can assess whether they are responding to treatment, say ICR researchers.
Professor Mel Greaves in lab
Video: Skin cancer risk may have driven evolution of black skin

26/02/14

Early humans may have evolved black skin to protect against a very high risk of dying from ultraviolet light-induced skin cancer, a new analysis concludes.
More intensive radiotherapy is better for localised prostate cancer

26/02/14

Results from a 10-year trial have shown that a radiotherapy regime involving higher doses of radiation is a better option than having lower doses for men with localised prostate cancer.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.